Delivery Order SPE2DB22D2211-SPE2DB25FSELM
- Not listed
- The Defense Logistics Agency awarded a $2,816.89 delivery order to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count packaging) on August 21, 2025, with completion scheduled for August 22, 2025. This contract represents a firm fixed-price, competitively awarded delivery order with no set-aside designation. The award was fulfilled by AmerisourceBergen Drug Corp's Corporate Office division, headquartered in Conshohocken, Pennsylvania, which serves as a major...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Drospirenone 4mg tablets in a 28-count package. This competitive, non-set-aside award carries a firm fixed price ceiling value of $7,458.51 and is scheduled for completion by September 24, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $8,093.94 to AmerisourceBergen Drug Corp for the supply of Drospirenone 4mg 28-count units under contract 4568868132. This firm fixed price delivery order, awarded on July 23, 2025, represents a non-competitive set-aside contract with an ultimate completion date of August 19, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $3,756.98 order is for the delivery of 4563715937 - DROSPIRENONE-EE 3-0.02 MG TAB 28S, a pharmaceutical product, to be delivered by February 21, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp, through its Corporate Office division in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,437.99 for Junel FE 1 mg-20 mcg tablets (28-count), a hormonal contraceptive medication. The contract was competitively awarded without set-aside designation on September 3, 2025, with an ultimate completion date of September 4, 2025. Performance will be executed from the company's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency Troop Support Medical awarded a $3,448.82 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for the delivery of 4561522410 Drospirenone-EE 3-0.02 mg tab 28s. The place of performance is Conshohocken, Pennsylvania. The contract period of performance is July 17, 2023 through July 18, 2023. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical product to support the Defense...
- The Defense Logistics Agency awarded a $3,237.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norgestimate-EE 0.25-0.035 mg 28-tablet pack pharmaceutical supplies. The contract was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under a larger indefinite delivery contract vehicle. This...
- This is a $1,034.44 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DROSPIRENONE-EE 3-0.02 MG TAB 28S medication, with a performance period ending on May 27, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX. This IDC provides a comprehensive...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,766.29 for Levonorgestrel 1.5mg tablets from the Medical Supply Chain, a division of the Defense Logistics Agency. The award was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, under a firm fixed-price contract type with no set-aside designation. This delivery order is a child contract under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,217.22 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Norgestimate-EE 0.25-0.035 mg in a 28-tablet package. This non-set-aside, firm fixed price delivery order was competitively awarded and is scheduled for completion by August 28, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's broader federal...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSELMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,744.56 to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count), a hormonal contraceptive medication. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of medications and medical supplies to military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contract history demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains on a competitive basis. This delivery order exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through the flexible Pharmaceutical Prime Vendor vehicle, enabling timely distribution of critical medical commodities to military personnel and beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/8/25 |